About My Health Careers Internship MedBlogs Contact us
Medindia
LOGIN REGISTER
Advertisement

Antiviral Therapy Improves Survival Rates for Kidney Transplant Recipients With Hepatitis: Study

by Colleen Fleiss on March 19, 2019 at 12:11 AM
Font : A-A+

Antiviral Therapy Improves Survival Rates for Kidney Transplant Recipients With Hepatitis: Study

Hepatitis B and C viral control was found to improve kidney transplant survival rates, stated study published in the Journal of Hepatology.

Renal transplantation is currently the best treatment for patients with end-stage renal disease (ESRD) because it significantly improves survival compared to patients who remain on hemodialysis. Since the 1990s, antiviral therapy using nucleos(t)ide analogues like adefovir, lamivudine, tenofovir, and entecavir, has benefited HBV-infected patients by preventing viral replication in infected cells. Interferon-based therapy has been rarely used in HCV-infected patients because it increases the risk of transplant rejection. Although the prevalence of HBV and HCV infection in patients with ESRD has significantly declined over time, it remains at least four times higher than in the general population.

Advertisement


"With the improvement of HBV treatment in the last two decades and the development of new treatments against HCV, an update of data in large cohorts of kidney transplant recipients with long-term follow-up was warranted," explained lead investigator Philippe Mathurin, MD, PhD, CHRU de Lille, Chief, Service des maladies de l'appareil digestif, Université Lille 2 and Inserm U795, Lille, France.

To reassess the impact of HBV and HCV on patient and kidney transplant graft survival, researchers analyzed records of more than 30,000 kidney transplant recipients using the French national database CRISTAL, including 575 recipients with HBV, 1,060 with HCV, and 29,798 who were free from infection. The first step of this study compared prognoses in these three groups and confirmed a poorer prognosis in HCV-infected patients than in non-infected patients. In contrast, there was no significant difference in patient and graft survival in HBV-infected patients compared with non-infected patients.
Advertisement

In the second step of this study, a random analysis of the medical records of 184 HBV and 504 HCV patients showed a control of viral replication in 94 percent and 35 percent of cases, respectively. For each kidney transplant recipient with HCV with detectable or undetectable HCV RNA, researchers randomly selected one to four matched controls from the 29,797 non-infected patients using the following matching criteria: gender, age, duration of dialysis, duration of cold ischemia, and year of transplantation. This analysis provided evidence that HBV chronic infection, which previously had a negative impact on patient and survival in kidney transplant patients, no longer influences patient or graft survival due to the control of viral replication related to the extensive use of nucleos(t)ide analogues. In contrast, HCV chronic infection still negatively impacts 10-year patient and graft survival. However, HCV's negative influence is counteracted by sustained viral suppression, since it is no longer observed in kidney transplant recipients with undetectable HCV RNA.

"The control of viral replication is a key factor in kidney transplant recipients," commented Dr. Mathurin. "The present results suggest, in line with international and KDIGO (Kidney Disease: Improving Global Outcomes) guidelines, that antiviral therapy should be systematically offered to HBV- and/or HCV-infected kidney transplant recipients or candidates to prevent the impact of chronic viral replication. Antiviral therapy with nucleos(t)ide analogues or direct antiviral agents should systematically be proposed, considering the major impact on patient and graft survival."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Emotional Healing
Psychosis Risk Related to Cat Parasite
Sedentary Behavior Precipitates Night-Time Hot Flashes
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Urinary Stones In Children Vesico-Ureteric Reflux Causing UTI in Children Hydronephrosis / Antenatal Counseling Reiki and Pranic Healing Kidney Disease Kidney Kidney Health Stones in Urinary Tract Renal Tubular Acidosis Transplantation 

Recommended Reading
HBV Screening
Tests used for screening hepatitis B are estimation of hepatitis B surface antigen (HBsAg), ......
Paired Donor Exchange Kidney Transplantation
Paired donor exchange kidney transplantation is a process in which unrelated kidney donors are ......
Quiz on Hepatitis
Hepatitis is a common liver disease that is responsible for mortality as well as morbidity. Test .....
New Option to Increase Kidney Transplantation for Minorities
Kidney transplant recipients are now benefiting from donor organs that do not match their blood ......
Hydronephrosis / Antenatal Counseling
Currently most pregnant women undergo one or two ultrasound scans during their pregnancy....
Renal Tubular Acidosis
Renal tubular acidosis/RTA results in acid content of the blood being higher than normal and that of...
Stones in Urinary Tract
Ask people who have suffered from urinary stones and they will tell you how excruciating the pain ca...
Transplantation
Organ and tissue transplantation can give a second chance at life to thousands of people. Learn more...
Urinary Stones In Children
There is a wide misconception that only adults develop stones. On the contrary kidney stones are ver...
Vesico-Ureteric Reflux Causing UTI in Children
Bacterial infection of urinary bladder can cause pain and burning sensation while passing urine. Abn...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use